Kanagawa, Japan

Hideaki Hanaki



Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 17(Granted Patents)


Location History:

  • Hiratsuka, JP (2001)
  • Kanagawa, JP (2005 - 2011)

Company Filing History:


Years Active: 2001-2011

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Hideaki Hanaki

Introduction

Hideaki Hanaki is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of microbiology and pharmaceuticals, particularly in the development of antibacterial agents. With a total of 3 patents, his work has the potential to impact the treatment of infectious diseases.

Latest Patents

Hanaki's latest patents include the K04-0144 substance and a process for production thereof. This invention involves a microorganism represented by a strain K04-0144, which has the ability to produce K04-0144 substances. These substances exhibit strong antibacterial activities against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). Consequently, they are useful as therapeutic agents for infectious diseases caused by MRSA and other multidrug-resistant bacteria. Additionally, the novel K04-0144D substance enhances the effect of β-lactam antibiotics, making it a valuable therapeutic agent in combination treatments. Another significant patent involves cephem compounds and ESBL-detecting reagents, which are crucial in the pharmaceutical industry.

Career Highlights

Throughout his career, Hanaki has worked with reputable organizations such as Zenyaku Kogyo Kabushiki Kaisha and The Kitasato Institute. His experience in these institutions has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of Hanaki's notable coworkers include Seiichiro Kawashima and Keiichi Hiramatsu. Their collaborative efforts have further advanced the research and development of innovative antibacterial agents.

Conclusion

Hideaki Hanaki's contributions to the field of microbiology and pharmaceuticals are noteworthy. His innovative patents and collaborations have the potential to significantly impact the treatment of infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…